Interventions and Outcomes in Patients with Infectious Pseudomonas scleritis: A 10-Year Perspective

Sumayya Ahmad, Michelle Lopez, Marwan Attala, Anat Galor, Natalie A. Stanciu, Darlene Miller, Leejee Suh, Thomas Albini, Victor L. Perez, Carol L. Karp, Janet L. Davis, Eduardo Alfonso, Richard K. Forster, Guillermo Amescua

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Purpose: To identify interventional factors associated with improved visual results and faster time to resolution for patients with Pseudomonas scleritis. Methods: Retrospective study analyzing inciting factors, therapeutic modalities, and outcomes of patients with Pseudomonas scleritis. Results: A total of 24 patients were analyzed; 22 were treated as outpatients. All had resolution of infection and 58% (n = 14) maintained ≥20/200 vision. Medical therapy included topical and oral antibiotics; seven received additional subconjunctival injections; two were admitted for IV antibiotics. Patients presenting with ≥20/200 vision were more likely to maintain this level of vision (n = 8, 80%) compared to those presenting with severe vision loss (n = 5, 36%) (p = 0.04). A similar proportion of patients who received (n = 8, 61%) and did not receive (n = 5, 39%) oral steroids achieved 20/200 vision or better once infection resolved, p = 1.0. Conclusions: Pseudomonas scleritis can be successfully managed in the outpatient setting. Oral steroids do not appear harmful in the treatment of this disease.

Original languageEnglish
Pages (from-to)499-506
Number of pages8
JournalOcular Immunology and Inflammation
Issue number3
StatePublished - 3 Apr 2019


  • Infectious scleritis
  • Pseudomonas
  • review
  • steroids


Dive into the research topics of 'Interventions and Outcomes in Patients with Infectious Pseudomonas scleritis: A 10-Year Perspective'. Together they form a unique fingerprint.

Cite this